Sign inGet started

Takeda Ventures, Inc.

Insider CIK 1771657 · CALA 10% owner · CRTX 10% owner · XLO 10% owner · DAWN 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CALA Calithera Biosciences, Inc J Other deriv2023-04-172023-05-261,000,000— $00SEC↗
CALA Calithera Biosciences, Inc J Other deriv2022-07-012022-07-061,000,000— $01,000,000SEC↗
CALA Calithera Biosciences, Inc J Other deriv2022-07-012022-07-061,000,000— $00SEC↗
DAWN Day One Biopharmaceuticals S Sale2021-12-082021-12-09110,338$18.03 $1.99M6,120,124SEC↗
DAWN Day One Biopharmaceuticals S Sale2021-12-072021-12-09128,745$18.43 $2.37M6,288,652SEC↗
DAWN Day One Biopharmaceuticals S Sale2021-12-072021-12-0958,190$19.50 $1.13M6,230,462SEC↗
DAWN Day One Biopharmaceuticals S Sale2021-12-062021-12-0797,692$18.05 $1.76M6,417,397SEC↗
DAWN Day One Biopharmaceuticals S Sale2021-12-032021-12-0712,517$18.47 $231.2K6,515,089SEC↗
DAWN Day One Biopharmaceuticals J Other2021-11-242021-11-2957,224— $06,527,606SEC↗
XLO Xilio Therapeutics, Inc. C Conversion deriv2021-10-262021-10-261,248,180— $00SEC↗
XLO Xilio Therapeutics, Inc. C Conversion deriv2021-10-262021-10-26226,941— $00SEC↗
XLO Xilio Therapeutics, Inc. C Conversion2021-10-262021-10-261,475,121— $01,475,121SEC↗
CRTX Cortexyme, Inc. C Conversion deriv2019-05-132019-05-132,360,071— $00SEC↗
CRTX Cortexyme, Inc. C Conversion deriv2019-05-132019-05-13319,731— $00SEC↗
CRTX Cortexyme, Inc. C Conversion2019-05-132019-05-132,679,802— $02,679,802SEC↗